These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19183967)

  • 1. Hydrolysis of 3,4-methylenedioxymethamphetamine (MDMA) metabolite conjugates in human, squirrel monkey, and rat plasma.
    Mueller M; Kolbrich-Spargo EA; Peters FT; Huestis MA; Ricaurte GA; Maurer HH
    Anal Bioanal Chem; 2009 Mar; 393(6-7):1607-17. PubMed ID: 19183967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validated liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxymethamphetamine in squirrel monkey plasma.
    Mueller M; Peters FT; Ricaurte GA; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(2):262-70. PubMed ID: 17646137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous liquid chromatographic-electrospray ionization mass spectrometric quantification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its metabolites 3,4-dihydroxymethamphetamine, 4-hydroxy-3-methoxymethamphetamine and 3,4-methylenedioxyamphetamine in squirrel monkey and human plasma after acidic conjugate cleavage.
    Mueller M; Peters FT; Huestis MA; Ricaurte GA; Maurer HH
    Forensic Sci Int; 2009 Jan; 184(1-3):64-8. PubMed ID: 19131196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further studies on the role of metabolites in (+/-)-3,4-methylenedioxymethamphetamine-induced serotonergic neurotoxicity.
    Mueller M; Yuan J; Felim A; Neudörffer A; Peters FT; Maurer HH; McCann UD; Largeron M; Ricaurte GA
    Drug Metab Dispos; 2009 Oct; 37(10):2079-86. PubMed ID: 19628751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS.
    Helmlin HJ; Bracher K; Bourquin D; Vonlanthen D; Brenneisen R
    J Anal Toxicol; 1996 Oct; 20(6):432-40. PubMed ID: 8889680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion of the main metabolites of 3,4-methylenedioxymethamphetamine (MDMA), including the sulfate and glucuronide of 4-hydroxy-3-methoxymethamphetamine (HMMA), in humans and rats.
    Shima N; Katagi M; Kamata H; Zaitsu K; Kamata T; Nishikawa M; Miki A; Tsuchihashi H; Sakuma T; Nemoto N
    Xenobiotica; 2008 Mar; 38(3):314-24. PubMed ID: 18274959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses.
    Mueller M; Peters FT; Maurer HH; McCann UD; Ricaurte GA
    J Pharmacol Exp Ther; 2008 Oct; 327(1):38-44. PubMed ID: 18591215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of LC-HRMS and GC-NICI-MS methods for stereoselective determination of MDMA and its phase I and II metabolites in human urine.
    Schwaninger AE; Meyer MR; Huestis MA; Maurer HH
    J Mass Spectrom; 2011 Jul; 46(7):603-14. PubMed ID: 21656610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxymethamphetamine in rat brain.
    Mueller M; Peters FT; Ricaurte GA; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Oct; 874(1-2):119-24. PubMed ID: 18829400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3,4-Dihydroxymethamphetamine (HHMA). A major in vivo 3,4-methylenedioxymethamphetamine (MDMA) metabolite in humans.
    Segura M; Ortuño J; Farré M; McLure JA; Pujadas M; Pizarro N; Llebaria A; Joglar J; Roset PN; Segura J; de La Torre R
    Chem Res Toxicol; 2001 Sep; 14(9):1203-8. PubMed ID: 11559034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats.
    Schindler CW; Thorndike EB; Blough BE; Tella SR; Goldberg SR; Baumann MH
    Br J Pharmacol; 2014 Jan; 171(1):83-91. PubMed ID: 24328722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites in human samples including the catechol-type metabolite (3,4-dihydroxymethamphetamine).
    Pizarro N; Farré M; Pujadas M; Peiró AM; Roset PN; Joglar J; de la Torre R
    Drug Metab Dispos; 2004 Sep; 32(9):1001-7. PubMed ID: 15319342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct comparison of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") disposition and metabolism in squirrel monkeys and humans.
    Mueller M; Kolbrich EA; Peters FT; Maurer HH; McCann UD; Huestis MA; Ricaurte GA
    Ther Drug Monit; 2009 Jun; 31(3):367-73. PubMed ID: 19417716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion kinetics of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its phase I and phase II metabolites in humans following controlled MDMA administration.
    Schwaninger AE; Meyer MR; Barnes AJ; Kolbrich-Spargo EA; Gorelick DA; Goodwin RS; Huestis MA; Maurer HH
    Clin Chem; 2011 Dec; 57(12):1748-56. PubMed ID: 21980168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis.
    Pizarro N; Ortuño J; Farré M; Hernández-López C; Pujadas M; Llebaria A; Joglar J; Roset PN; Mas M; Segura J; Camí J; de la Torre R
    J Anal Toxicol; 2002 Apr; 26(3):157-65. PubMed ID: 11991532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gas chromatography-ion trap mass spectrometry method for the simultaneous measurement of MDMA (ecstasy) and its metabolites, MDA, HMA, and HMMA in plasma and urine.
    da Silva DG; de Pinho PG; Pontes H; Ferreira L; Branco P; Remião F; Carvalho F; Bastos ML; Carmo H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(9-10):815-22. PubMed ID: 20167546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the rat.
    Concheiro M; Baumann MH; Scheidweiler KB; Rothman RB; Marrone GF; Huestis MA
    Drug Metab Dispos; 2014 Jan; 42(1):119-25. PubMed ID: 24141857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chiral Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine and its Phase I and II Metabolites following Controlled Administration to Humans.
    Steuer AE; Schmidhauser C; Schmid Y; Rickli A; Liechti ME; Kraemer T
    Drug Metab Dispos; 2015 Dec; 43(12):1864-71. PubMed ID: 26395866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-dimensional gas chromatography/electron-impact mass spectrometry with cryofocusing for simultaneous quantification of MDMA, MDA, HMMA, HMA, and MDEA in human plasma.
    Kolbrich EA; Lowe RH; Huestis MA
    Clin Chem; 2008 Feb; 54(2):379-87. PubMed ID: 18089653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection and optimization of hydrolysis conditions for the quantification of urinary metabolites of MDMA.
    Pirnay SO; Abraham TT; Lowe RH; Huestis MA
    J Anal Toxicol; 2006 Oct; 30(8):563-9. PubMed ID: 17132253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.